| abstract |
The present invention relates to the use of a lysozyme dimer for the manufacture of a pharmaceutical composition for the stimulation of non-specific cellular of humoral defense mechanisms of the immune system of a human or animal individual. The stimulation comprises increasing phagocytic activity and increasing at least one parameter selected from the group consisting of ceruioplasmin level, respiratory burst activity, immunoglobulin level, and lysozyme activity. The stimulation optionally further comprises regulating serum levels of free oxygen radicals. The pharmaceutical composition may be used for preventing or treating leukaemia, hair growth disorders, fish diseases and bee diseases. |